Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Lebanon, USA
16 Cavendish Court
Lebanon, NH, 03766
USA

People

VP, Head, Business Development
VP & Head, Computational Biology
Board of Directors
Board Director
Board of Directors
Board Director
Board of Directors
Director, Antibody Discovery & Optimization
Show All People

Funding

TOTAL $39.7M
FUNDING TOTAL $39.7M
Series A, 7/2007
$400k
Venture Round, 7/2007
$2.38k
Series A, 9/2007
Polaris Partners
SV Life Sciences
$5.9M
Series B, 4/2008
$3.18M
Series C, 11/2008
OrbiMed Advisors
Borealis Ventures
Polaris Partners
SV Life Sciences
$4M
Series D, 1/2010
Google Ventures
OrbiMed Advisors
Borealis Ventures
Polaris Partners
SV Life Sciences
$8.2M
Venture Round, 12/2010
$4M
Series F, 4/2012
Venture Round, 4/2012
Google Ventures
Polaris Partners
SV Life Sciences
$14M

Tags

Adimab

Adimab’s integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.

Recent Milestones

  • Dollar
    Adimab received $14M in Venture Round funding. (4/3/12)
    Posted 4/3/12 at 8:04pm via fiercebiotech.com
  • Dollar
    Adimab received () in Series F funding. (4/2/12)
    Posted 4/2/12 at 6:36pm via adimab.com
  • Dollar
    Adimab received $4M in Venture Round funding. (12/1/10)
    Posted 12/1/10 at 10:57pm via masshightech.com
  • Dollar
    Adimab received $8.2M in Series D funding. (1/22/10)
    Posted 1/22/10 at 4:28pm via onbiovc.com
  • Dollar
    Adimab received $4M in Series C funding. (11/20/08)
    Posted 1/22/10 at 4:28pm via adimab.com
  • Dollar
    Adimab received $3.18M in Series B funding. (4/1/08)
    Posted 2/24/10 at 3:59pm via sec.gov
  • Dollar
    Adimab received $5.9M in Series A funding. (9/21/07)
    Posted 2/24/10 at 3:57pm via sec.gov
  • Dollar
    Adimab received $2.38k in Venture Round funding. (7/16/07)
    Posted 2/24/10 at 3:57pm via sec.gov
  • Dollar
    Adimab received $400k in Series A funding. (7/1/07)
    Posted 2/24/10 at 3:57pm via sec.gov
  • Check
    Adimab added K. Dane Wittrup as Co - Founder, Office Of The CSO & Chairman, SAB. (1/1/07)
    Posted 6/4/13 at 10:08pm
  • Check
    Adimab added Tillman Gerngross as Co - Founder & CEO & Board Director.
    Posted 5/14/11 at 6:18pm

Videos

Screenshots

Sources

  1. SEC D (sec.gov) [edit]
  2. SEC D (sec.gov) [edit]
  3. SEC D (sec.gov) [edit]
  4. SEC D (sec.gov) [edit]
  5. Adimab, Inc. Announces Series C Financing (adimab.com) [edit]
  6. Adimab, Inc.: Series D $8.2M (onbiovc.com) [edit]
  7. NH biotech startup Adimab attracts $4M funding (masshightech.com) [edit]
  8. Adimab Completes Series F Financing - Acquires New Research Facility to Accommodate Growth (adimab.com) [edit]
  9. Google contributes to $14M round for fast-growing Adimab (fiercebiotech.com) [edit]
Edit This Page
Last Edited 12/4/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy